Wealthfront Logo

SPDR S&P Biotech ETF

XBI - US stocks
XBI seeks to track the performance of the S&P Biotechnology Select Industry Index, which contains the stocks of US companies in the biotechnology industry. XBI is appropriate for investors seeking long-term growth from targeted exposure to biotechnology companies.The fund holds a smaller and less diversified selection of stocks than a broad index fund, and may be more volatile.
XBI isn’t eligible for Tax-Loss Harvesting, since we can’t find a viable alternate fund.
  • Price
    $93.40
    as of 04:00 PM EST, 12/13/2024
  • Risk rating
    Very high
    We base risk ratings on the volatility, or the size and frequency of price fluctuations, of the investment. Typically, a more volatile investment has a higher risk rating.
  • Expense ratio
    0.35%
    The percentage of fund assets used to cover operating expenses and management fees.
  • 52-week high
    $105.47
    The highest share price in the past year.
  • 52-week low
    $77.78
    The lowest share price in the past year.
  • Dividend yield
    0.15%
    The average percentage of dividends paid relative to the share price over the past year.
  • Net assets
    $6.54B
    The total value of all assets held by the fund.
  • Volume
    8,467,323
    The average trading volume over the past 90 days.
View prospectus

Investing is easy

when it’s automated

Start with one of Wealthfront’s expert-built portfolios and then customize your portfolio with hundreds of investment possibilities.

Get started